Shire cutting up to 180 U.K. jobs, plus more in Switzerland

Shire ($SHPG) is confirming reports that it plans to significantly cut back on its sizable research operations in Basingstoke, U.K.--another setback for the country's research industry, with Novartis ($NVS) axing more than 500 staffers and consultants in Horsham following major blows from AstraZeneca ($AZN) and Pfizer ($PFE). More Shire layoffs are being prepped in Switzerland, where the company is relocating offices from Eysins to Zug. Report

Suggested Articles

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.

While the FDA gave an emergency green light to chloroquine's use against coronavirus, European regulators are restricting the drug to clinical trials.

Biocon has finally satisfied the FDA that its insulin production plant in Malaysia is ready for prime time.